Ocugen, Inc. (LS:A2PSZH) Financings

Ocugen, Inc.

Financings

RaiseDate
6.75% convertible senior notes due 2034
Update: US$115M–US$130M
Use of proceeds: $32.7 million to retire the Avenue debt; remaining net proceeds for general corporate purposes
May 5, 2026
Public offering of common stock
Announced: US$22.5M · US$1.5 a share · Oppenheimer & Co.
Dealers: Oppenheimer & Co. (lead)
Buyers: RTW Investments
Use of proceeds: General corporate purposes, capital expenditures, working capital, and general and administrative expenses
Jan 21, 2026
Registered direct offering of common stock and warrants
Closed: US$20M raised · US$1 a share · Warrants at US$1.5 for 24 months · Noble Capital Markets, Inc. +2
Dealers: Noble Capital Markets, Inc. (lead), Maxim Group LLC, Titan Partners Group
Buyers: Janus Henderson Investors (20,000,000 shares of common stock and warrants to purchase up to 20,000,000 shares)
Use of proceeds: Extend the company's cash runway into the second quarter of 2026
Aug 12, 2025

Read by 6ix AI from the company's releases